Skip to main content
Clinical Trials/CTRI/2024/05/067431
CTRI/2024/05/067431
Recruiting
Phase 3

Comparing survival outcomes between neoadjuvant chemotherapy vs upfront surgery in resectable periampullary carcinoma a prospective open label randomized controlled trial - NI

AIIMS PATNA0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: C248- Malignant neoplasm of overlappingsites of biliary tract
Sponsor
AIIMS PATNA
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
AIIMS PATNA

Eligibility Criteria

Inclusion Criteria

  • 1\.Periampullary carcinoma which are resectable on imaging studies
  • 2\.ECOG grade 0\-II
  • 3\.Biopsy proven periampullary carcinoma

Exclusion Criteria

  • 1\.Borderline resectable and locally advanced disease
  • 2\.Contraindication to use of chemotherapy
  • 3\.Ca head of pancreas

Outcomes

Primary Outcomes

Not specified

Similar Trials